2023 Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Marie Robin Journal Hemasphere.
2023 Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP) Group Acute Leukemia Working Party (ALWP) 1st listed author Eleni Gavriilaki Journal Bone Marrow Transplant.
2023 The European Society for Blood and Marrow Transplantation (EBMT) roadmap and perspectives to improve nutritional care in patients undergoing hematopoietic stem cell transplantation on behalf of the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Nurses Group (NG) of the EBMT Group Cellular Therapy & Immunobiology Working Party (CTIWP) Nursing Research Committee 1st listed author Amanda Casirati Journal Bone Marrow Transplant.
2023 Variation in hydration use after reinfusion of autologous stem cells in dimethyl sulfoxide (DMSO): a survey of EBMTcenters on behalf of the EBMT Nurses Group Group Nursing Research Committee 1st listed author Jantina P Kortleve Journal Bone Marrow Transplant.
2023 Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Mohamed A Kharfan-Dabaja Journal Hemasphere.
2023 Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) Group Acute Leukemia Working Party (ALWP) 1st listed author Enrico Maffini Journal Bone Marrow Transplant.
2023 Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT) Group Acute Leukemia Working Party (ALWP) 1st listed author Mohamad Mohty Journal Bone Marrow Transplant.
2023 Unrelated or haploidentical allogeneic hematopoietic cell transplantation in second complete remission for acute myeloid leukemia-Improved outcomes over time: A European Society for Blood and Marrow Transplantation Acute Leukemia Working Party study Group Acute Leukemia Working Party (ALWP) 1st listed author Rama Al Hamed Journal Cancer.
2023 Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation Group Acute Leukemia Working Party (ALWP) 1st listed author Arnon Nagler Journal Bone Marrow Transplant.
2023 An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT Group Chronic Malignancies Working Party (CMWP) 1st listed author Meral Beksac Journal Bone Marrow Transplant.
2023 Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society of Blood and Marrow Transplantation Group Severe Aplastic Anaemia Working Party (SAAWP) 1st listed author Simona Pagliuca Journal Haematologica.
2023 Outcomes of graft failure after umbilical cord blood transplantation in acute leukemia: a study from Eurocord and the Acute Leukemia Working Party of the EBMT Group Acute Leukemia Working Party (ALWP) 1st listed author Frédéric Baron Journal Bone Marrow Transplant.